The purpose of this study is to see if adding LY3537982 to standard cancer treatments works better than just using the standard treatments alone for people with advanced non-small cell lung cancer (NSCLC) who have not yet been treated.
Thank you for your interest, but this study is not currently enrolling.
United States (Nationwide)
Shetal Patel
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Lung)
24-2028
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
